E-LIB Suche - Ergebnisse für: McLaughlin, V

1

Exercise echocardiography and speckle tracking interest to ..:

Fauvel, C. ; Cascino, T. ; Moles, V....
Archives of Cardiovascular Diseases Supplements. 15 (2023) 1 - p. 70 , 2023

Link: https://doi.org/10.1016/..

2

UNISUS study design: a phase 3 superiority study comparing ..:

McLaughlin, V ; Hoeper, M ; Tamura, Y...
European Heart Journal. 43 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

3

Concomitant initiation of combination therapy with macitent..:

Channick, R ; Chin, K M ; Kim, N H...
European Heart Journal. 43 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

4

Treatment effect of selexipag on time to disease progressio..:

Coghlan, G J ; Gaine, S ; Channick, R N...
European Heart Journal. 42 (2021) Supplement_1 - p. , 2021

Link: https://doi.org/10.1093/..

5

PCV3 Hospitalization Rates and Association with Survival Ri..:

Kim, N. ; Farber, H.W. ; Highland, K....
Value in Health. 23 (2020) - p. S486 , 2020

Link: https://doi.org/10.1016/..

6

Treatment with macitentan for pulmonary arterial hypertensi..:

McLaughlin, V ; Chin, K ; Kim, N.H...
European Heart Journal. 41 (2020) Supplement_2 - p. , 2020

Link: https://doi.org/10.1093/..

7

Characteristics and clinical course of the first 500 patien..:

McLaughlin, V ; Highland, K.B ; Hemnes, A.R...
European Heart Journal. 41 (2020) Supplement_2 - p. , 2020

Link: https://doi.org/10.1093/..

8

PCV2 Characterizing Patients Treated with Macitentan: Real-..:

Kim, N. ; Chin, K.M. ; McLaughlin, V.V....
Value in Health. 23 (2020) - p. S486 , 2020

Link: https://doi.org/10.1016/..

9

Combination therapy with macitentan and phosphodiesterase t..:

McLaughlin, V ; Channick, R ; Kim, N.H...
European Heart Journal. 41 (2020) Supplement_2 - p. , 2020

Link: https://doi.org/10.1093/..

10

Long-term outcomes in newly diagnosed pulmonary arterial hy..:

Galie, N ; Sitbon, O ; Doelberg, M...
European Heart Journal. 41 (2020) Supplement_2 - p. , 2020

Link: https://doi.org/10.1093/..

11

Outcomes associated with modern treatment paradigms in conn..:

McLaughlin, V ; Zhao, C ; Coghlan, J.G...
European Heart Journal. 41 (2020) Supplement_2 - p. , 2020

Link: https://doi.org/10.1093/..

12

P3674Patient characteristics and treatment patterns in the ..:

McLaughlin, V ; Channick, R ; Chin, K...
European Heart Journal. 40 (2019) Supplement_1 - p. , 2019

Link: https://doi.org/10.1093/..

13

THE IMPACT OF TIME FROM DIAGNOSIS AT BASELINE ON LONG-TERM ..:

Langleben, D. ; Gaine, S. ; Sitbon, O....
Canadian Journal of Cardiology. 35 (2019) 10 - p. S77 , 2019

Link: https://doi.org/10.1016/..

14

P3671Selexipag dosing and titration in the first 500 patien..:

McLaughlin, V ; Kim, N H ; Hemnes, A R...
European Heart Journal. 40 (2019) Supplement_1 - p. , 2019

Link: https://doi.org/10.1093/..

15

4973Efficacy and safety of selexipag in pulmonary arterial ..:

Rosenkranz, S ; Channick, R ; Chin, K...
European Heart Journal. 40 (2019) Supplement_1 - p. , 2019

Link: https://doi.org/10.1093/..